These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8638206)

  • 21. Prolonged paralysis with atracurium infusion.
    Snyder RW
    Crit Care Med; 1995 Jun; 23(6):1157-8. PubMed ID: 7774235
    [No Abstract]   [Full Text] [Related]  

  • 22. [Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium].
    Ebeling BJ; Keienburg T; Hausmann D; Apffelstaedt C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):304-8. PubMed ID: 8767244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-resistance to both atracurium- and vecuronium-induced neuromuscular blockade in a critically ill patient.
    Fish DN; Singletary TJ
    Pharmacotherapy; 1997; 17(6):1322-7. PubMed ID: 9399619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The shifting sands of mechanical ventilation.
    Hoyt JW
    Crit Care Med; 1998 Jul; 26(7):1162-3. PubMed ID: 9671363
    [No Abstract]   [Full Text] [Related]  

  • 25. [Muscle relaxants in the ICU].
    Schneider G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May; 44(5):358-64; quiz 366, 379. PubMed ID: 19440945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged paralysis after neuromuscular blockade.
    Gooch JL
    J Toxicol Clin Toxicol; 1995; 33(5):419-26. PubMed ID: 7650766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anaphylaxis by atracurium. One case report].
    Domínguez-Sansores L; González-Díaz S; Arias-Cruz A; Palacios-Rìos D; López-Cabrera NG
    Rev Alerg Mex; 2013; 60(2):78-81. PubMed ID: 24008107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels.
    Larsson L; Li X; Edström L; Eriksson LI; Zackrisson H; Argentini C; Schiaffino S
    Crit Care Med; 2000 Jan; 28(1):34-45. PubMed ID: 10667496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual disturbance and residual paralysis.
    Lam AM
    Anesthesiology; 1997 Nov; 87(5):1257-9. PubMed ID: 9366487
    [No Abstract]   [Full Text] [Related]  

  • 30. Further experiences with vercuronium in the horse.
    Martin-Flores M; Campoy L; Gleed RD
    Vet Anaesth Analg; 2012 Mar; 39(2):218-9. PubMed ID: 22356417
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prolonged paralysis after administration of pancuronium bromide].
    Salehi E
    Z Prakt Anasth Wiederbeleb Intensivther; 1972 Aug; 7(4):207-11. PubMed ID: 4269040
    [No Abstract]   [Full Text] [Related]  

  • 32. Incidence of intra-operative bradycardia. Comparison of atracurium and vecuronium in gynaecological surgery.
    Hameedullah H; Khan FA
    Anaesthesia; 1997 Dec; 52(12):1221-4. PubMed ID: 9485981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged weakness after cisatracurium infusion: a case report.
    Davis NA; Rodgers JE; Gonzalez ER; Fowler AA
    Crit Care Med; 1998 Jul; 26(7):1290-2. PubMed ID: 9671384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A response to 'Masseter muscle spasm following atracurium', Reddy K & Bromley L, Anaesthesia 2004; 59: 513.
    Jenkins G
    Anaesthesia; 2004 Jul; 59(7):733-4. PubMed ID: 15200573
    [No Abstract]   [Full Text] [Related]  

  • 35. [Utility of double burst stimulation in the detection of residual neuromuscular blockade].
    Ortiz JR
    Rev Esp Anestesiol Reanim; 1999 Feb; 46(2):71-4. PubMed ID: 10100441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.
    Mertes PM; Moneret-Vautrin DA; Leynadier F; Laxenaire MC
    Anesthesiology; 2007 Aug; 107(2):245-52. PubMed ID: 17667568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaphylaxis to neuromuscular-blocking drugs: all neuromuscular-blocking drugs are not the same.
    Mertes PM; Volcheck GW
    Anesthesiology; 2015 Jan; 122(1):5-7. PubMed ID: 25383569
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
    May JR; Rutkowski AF
    J Med Assoc Ga; 1994 Aug; 83(8):473-6, 484. PubMed ID: 7822974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early recognition of risk factors for persistent effects of vecuronium.
    Sanders KA; Aucker R
    South Med J; 1996 Apr; 89(4):411-4. PubMed ID: 8614883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal atracurium toxicity may be explained by atracurium moieties.
    Rieder J; Lirk P
    Paediatr Anaesth; 2002 Sep; 12(7):656-7. PubMed ID: 12358671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.